DETERMINATION OF HPRT MUTANT AND MUTATION FREQUENCIES AND THE MOLECULAR CHARACTERIZATION OF HUMAN-DERIVED IN-VIVO T-LYMPHOCYTE MUTANTS

被引:19
作者
CURRY, J
ROWLEY, GT
SADDI, V
BEARE, D
COLE, J
GLICKMAN, BW
机构
[1] UNIV VICTORIA,CTR ENVIRONM HLTH,VICTORIA,BC V8W 2Y2,CANADA
[2] UNIV VICTORIA,DEPT BIOL,VICTORIA,BC V8W 2Y2,CANADA
[3] UNIV SUSSEX,MRC,CELL MUTAT UNIT,BRIGHTON BN1 9RR,E SUSSEX,ENGLAND
[4] UNITED MED & DENT SCH,GUYS HOSP,DIV MED & MOLEC GENET,LONDON SE1 9RT,ENGLAND
关键词
HPRT; T-CELLS; HUMAN; IN VIVO; SPONTANEOUS MUTATION;
D O I
10.1002/em.2850250302
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Using a T-lymphocyte clonal assay, 73 6-thioguanine resistant T-lymphocytes were isolated from two blood samples obtained 4 months apart from a 50-year-old male subject. Sixty-six of these mutants were characterized at the DNA sequence level using cDNA. One particular single base substitution was recovered a total of 23 times. The majority of T-cell receptors (TCR) of these mutants all share a common gamma-TCR rearrangement, and thus likely represent a single mutational event that underwent clonal expansion in vivo. Siblings of this clone were recovered in both collections. Three other single base substitutions were also recovered more than once. In two of the three cases, the mutants were also found to be clonally related, while in one case they were not. A number of identical exon loss events were also recovered, yet none of these were clonally related. This probably reflects the multiple pathways by which these mutations can arise. The TCR data was used to correct the observed mutant frequency to produce an estimate of the actual mutation frequency. The two mutant frequencies, 18 x 10(-6) and 19 x 10(-6), obtained from the first and second sampling periods, respectively, can thus be corrected to yield true mutation frequency's of 12 x 10(-6) each. (C) 1995 Wiley-Liss, Inc.
引用
收藏
页码:169 / 179
页数:11
相关论文
共 36 条
[1]  
Albertini RJ, Castle KL, Borcherding WR, T‐cell cloning to detect the mutant 6‐thioguanine‐resistant lymphocytes present in human peripheral blood, Proc Natl Acad Sci USA, 79, pp. 6617-6621, (1982)
[2]  
Albertini RJ, O'Neill JP, Nicklas JA, Recio L, Skopek TR, Hprt mutations in in vivo in human T‐lymphocytes: Frequencies, spectra and clonality, Mutation and the Environment. Part C: Somatic and Heritable Mutation, Adduction, and Epidemiology, pp. 15-24, (1990)
[3]  
Akbar AN, Salmon M, Janossy G, The synergy between naive and memory T cells during activation, Immunol Today, 12, pp. 184-188, (1991)
[4]  
Ammenheuser MM, Ward JB, Whorton EB, Killian JM, Legator MS, Elevated frequencies of 6‐thioguanine‐resistant lymphocytes in multiple sclerosis patients treated with cyclophospha‐mide: A prospective study, Mutat Res, 204, pp. 509-520, (1988)
[5]  
Andersson B, Hou SM, Lambert B, Mutations causing defective splicing in the human HPRT gene, Environ Mol Mutagen, 20, pp. 89-95, (1992)
[6]  
Beare DM, Aldridge KE, O'Donovan MR, Cole J, An improved procedure for the in vitro expansion of human T‐lymphocyte clones for mutant analysis, Mutat Res, 291, pp. 207-212, (1993)
[7]  
Branda RF, Sullivan LM, O'Neill JP, Falta MT, Nicklas JA, Hirsch B, Vacek PM, Albertini RJ, Measurement of HPRT mutant frequencies in T‐lymphocytes from healthy human populations, Mutat Res, 285, pp. 267-279, (1993)
[8]  
Breit TM, Wolvers-Tettero IL, Hahlen K, van Wering ER, van Dongen JJ, Extensive junctional diverity of gamma delta T‐lymphocyte receptors expressed by T‐lymphocyte acute lymphoblastic leukemias: Implications for the detection of minimal residual disease, Leukemia, 5, pp. 1076-1086, (1991)
[9]  
Bronstein SM, Cochrane JE, Craft TR, Swenberg JA, Skopek TR, Toxicity, mutagenicity and mutational spectra of N‐ethyl‐N'‐nitrosourea in human cell lines with different DNA repair phenotypes, Cancer Res, 51, pp. 5188-5197, (1991)
[10]  
Buckton KE, Court Brown WM, Smith PG, Lymphocyte survival in men treated with X‐rays for anklylosing spondylitis, Nature, 214, pp. 470-473, (1967)